Table 1.
Details of the Entire Cohort
| Subtype | No. (%) |
|---|---|
| B-cell acute lymphoblastic leukemia (n = 252) | |
| High hyperdiploidy | 79 (31.3) |
| Low hypodiploidy | 5 (2.0) |
| Near-haploid | 2 (0.8) |
| iAMP21 | 2 (0.8) |
| ETV6-RUNX1 | 47 (18.7) |
| KMT2A-r | 18 (7.1) |
| TCF3-PBX1 | 16 (6.3) |
| BCR-ABL1 | 11 (4.4) |
| DUX4-r | 15 (6.0) |
| MEF2D-r | 7 (2.8) |
| ZNF384-r | 12 (4.8) |
| NUTM1-r | 2 (0.8) |
| HLF-r | 1 (0.4) |
| ZEB2/CEBP | 1 (0.4) |
| PAX5alt | 16 (6.3) |
| Ph-like | 6 (2.4) |
| ETV6-RUNX1–like | 1 (0.4) |
| KMT2A-like | 1 (0.4) |
| B-cell other | 10 (4.0) |
| Total | 252 (100) |
| T-cell acute lymphoblastic leukemia (n = 43) | |
| TAL1 | 20 (46.5) |
| TAL2 | 1 (2.3) |
| TLX3 | 2 (4.7) |
| LMO1/2 | 2 (4.7) |
| NKX2-1 | 2 (4.7) |
| HOXA | 5 (11.6) |
| T-cell other | 11 (25.6) |
| Total | 43 (100) |